Ocular Therapeutix, Inc. (OCUL) vs Recursion Pharmaceuticals, Inc. (RXRX)
Ocular Therapeutix, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Ocular Therapeutix, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.1B). Ocular Therapeutix, Inc. grew revenue faster over the last twelve months: −8.14% against −15.1%. Ocular Therapeutix, Inc. has the higher net margin (−579.1% vs −945.9%) and the higher return on invested capital (0.00% vs −92.2%). Across the 18 metrics below, Ocular Therapeutix, Inc. leads on 9 and Recursion Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | OCUL | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.11% | 3.48% | 65.16% |
| Operating margin | (603.04%) | (991.72%) | 0.00% |
| Net margin | (579.10%) | (945.92%) | 0.00% |
| Free cash flow margin | (490.07%) | (645.82%) | 0.00% |
| Return on equity | (72.99%) | (56.58%) | (57.72%) |
| Return on assets | (53.70%) | (41.26%) | (49.22%) |
| Return on invested capital | 0.00% | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack